• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 在肌少脂性肥胖中的作用。

Vitamin D in Osteosarcopenic Obesity.

机构信息

School of Medicine, Vita-Salute San Raffaele University, Via Olgettina 58, 00132 Milan, Italy.

Institute of Endocrine and Metabolic Sciences, IRCCS San Raffaele Hospital, Via Olgettina 60, 00132 Milan, Italy.

出版信息

Nutrients. 2022 Apr 26;14(9):1816. doi: 10.3390/nu14091816.

DOI:10.3390/nu14091816
PMID:35565781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9100750/
Abstract

Osteosarcopenic obesity is a unique clinical condition where low bone and muscle mass coexist in individuals with obesity. Alterations in adipose tissue, skeletal muscle and bone are strictly interconnected, and vitamin D plays key roles in several metabolic pathways that are involved in maintaining musculoskeletal health and glucose homeostasis. We reviewed the available literature on mechanisms underlying osteosarcopenic obesity, with a focus on the role of vitamin D in the pathogenesis and treatment of the condition. We found that, although evidence from large observational studies and pre-clinical experiments strongly supports a role of vitamin D deficiency in the pathogenesis of osteosarcopenic obesity, the common belief that vitamin D improves musculoskeletal health lacks solid clinical evidence, as trials specifically aimed at assessing the effects of vitamin D supplementation in patients with osteosarcopenic obesity are not available, and trials that investigated the role of vitamin D on muscle and bone health in other patient populations either showed no or even detrimental effects. We conclude that large observational and interventional studies including individuals with osteosarcopenic obesity representative of different sex, age and race are needed to better define the role of vitamin D in the pathogenesis and treatment of this condition.

摘要

骨肌减少型肥胖症是一种独特的临床病症,其特征是肥胖个体同时存在低骨量和低肌肉量。脂肪组织、骨骼肌和骨骼的改变是严格相互关联的,维生素 D 在涉及维持肌肉骨骼健康和葡萄糖稳态的几个代谢途径中发挥着关键作用。我们回顾了关于骨肌减少型肥胖症发病机制的现有文献,重点关注了维生素 D 在该病症发病机制和治疗中的作用。我们发现,尽管来自大型观察性研究和临床前实验的证据强烈支持维生素 D 缺乏在骨肌减少型肥胖症发病机制中的作用,但普遍认为维生素 D 可改善肌肉骨骼健康,这一观点缺乏确凿的临床证据,因为目前尚无专门针对评估维生素 D 补充剂对骨肌减少型肥胖症患者影响的试验,而那些针对其他患者群体的维生素 D 对肌肉和骨骼健康作用的试验则显示出没有作用甚至有害作用。我们的结论是,需要进行包括具有不同性别、年龄和种族代表性的骨肌减少型肥胖症患者的大型观察性和干预性研究,以更好地确定维生素 D 在该病症发病机制和治疗中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcc/9100750/73c154bd2155/nutrients-14-01816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcc/9100750/9e966814b88f/nutrients-14-01816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcc/9100750/73c154bd2155/nutrients-14-01816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcc/9100750/9e966814b88f/nutrients-14-01816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcc/9100750/73c154bd2155/nutrients-14-01816-g002.jpg

相似文献

1
Vitamin D in Osteosarcopenic Obesity.维生素 D 在肌少脂性肥胖中的作用。
Nutrients. 2022 Apr 26;14(9):1816. doi: 10.3390/nu14091816.
2
Clinical Manifestations and Factors Associated with Osteosarcopenic Obesity Syndrome: A Cross-Sectional Study in Koreans with Obesity.临床表现及与肥胖相关性骨肌减少症的相关因素:一项韩国肥胖人群的横断面研究。
Calcif Tissue Int. 2019 Jul;105(1):77-88. doi: 10.1007/s00223-019-00551-y. Epub 2019 Apr 17.
3
Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008-2010.血清维生素D与骨质疏松性肥胖的关联:2008 - 2010年韩国国家健康与营养检查调查
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):259-266. doi: 10.1002/jcsm.12154. Epub 2016 Oct 5.
4
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.是否有足够的证据将肌骨减少性肥胖视为一种独特的实体?一项批判性文献综述。
Calcif Tissue Int. 2019 Aug;105(2):109-124. doi: 10.1007/s00223-019-00561-w. Epub 2019 May 16.
5
Muscle Traits, Sarcopenia, and Sarcopenic Obesity: A Vitamin D Mendelian Randomization Study.肌肉特征、少肌症和肌少症性肥胖:维生素 D 的孟德尔随机研究。
Nutrients. 2023 Jun 9;15(12):2703. doi: 10.3390/nu15122703.
6
Sarcopenic Obesity in People with Alcoholic Use Disorder: Relation with Inflammation, Vascular Risk Factors and Serum Vitamin D Levels.酒精使用障碍患者的肌肉减少性肥胖:与炎症、血管风险因素和血清维生素 D 水平的关系。
Int J Mol Sci. 2023 Jun 9;24(12):9976. doi: 10.3390/ijms24129976.
7
Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance.骨肌减少性肥胖及其组成部分(骨质疏松症、肌少症和肥胖症)与胰岛素抵抗的关系。
J Bone Miner Metab. 2020 Sep;38(5):695-701. doi: 10.1007/s00774-020-01104-2. Epub 2020 Apr 25.
8
Sarcopenia in post-menopausal women: Is there any role for vitamin D?绝经后女性的肌肉减少症:维生素D有作用吗?
Maturitas. 2015 Sep;82(1):56-64. doi: 10.1016/j.maturitas.2015.03.014. Epub 2015 Mar 27.
9
Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women.骨肌少性肥胖与绝经后女性握力降低、行走能力及平衡能力下降有关。
Osteoporos Int. 2015 Nov;26(11):2587-95. doi: 10.1007/s00198-015-3186-y. Epub 2015 May 30.
10
Vitamin D supplementation and muscle strength in pre-sarcopenic elderly Lebanese people: a randomized controlled trial.维生素 D 补充与肌少症前期老年黎巴嫩人肌肉力量:一项随机对照试验。
Arch Osteoporos. 2018 Dec 19;14(1):4. doi: 10.1007/s11657-018-0553-2.

引用本文的文献

1
Exploring the link between osteosarcopenia and osteoarthritis in prediabetic adults using NHANES data.利用美国国家健康与营养检查调查(NHANES)数据探究糖尿病前期成年人中骨少肌少症与骨关节炎之间的联系。
Sci Rep. 2025 Jun 5;15(1):19747. doi: 10.1038/s41598-025-95344-9.
2
Progression of obesity and abdominal obesity after the COVID-19 pandemic in Colombia: a comparison of two cross-sectional population-based studies.哥伦比亚新冠疫情后肥胖及腹型肥胖的进展:两项基于人群的横断面研究比较
BMJ Public Health. 2025 May 13;3(1):e001075. doi: 10.1136/bmjph-2024-001075. eCollection 2025.
3
Multifactorial Determinants of Body Composition in the Korean Older Adults: Using Data from the 2022-2023 National Health and Nutrition Examination Survey.

本文引用的文献

1
Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis.维生素 D 单药治疗对社区居住老年人肌少症指标的影响:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1642-1652. doi: 10.1002/jcsm.12976. Epub 2022 Mar 8.
2
Relationship between oseteoporosis with fatty infiltration of paraspinal muscles based on QCT examination.基于定量CT检查的骨质疏松症与椎旁肌脂肪浸润之间的关系。
J Bone Miner Metab. 2022 May;40(3):518-527. doi: 10.1007/s00774-022-01311-z. Epub 2022 Mar 3.
3
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.
韩国老年人身体成分的多因素决定因素:基于2022 - 2023年全国健康与营养检查调查的数据
Nutrients. 2025 Apr 27;17(9):1477. doi: 10.3390/nu17091477.
4
Obesity and blunted FGF23 response associate with kidney impairment in patients with hypoparathyroidism.肥胖和FGF23反应迟钝与甲状旁腺功能减退患者的肾功能损害相关。
Endocrine. 2025 Apr 16. doi: 10.1007/s12020-025-04221-y.
5
Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications-A Narrative Review.维生素D与2型糖尿病:分子机制及临床意义——一篇叙述性综述
Int J Mol Sci. 2025 Feb 27;26(5):2153. doi: 10.3390/ijms26052153.
6
A cohort study of serum 25-hydroxyvitamin D levels and the risk of hyperlipidaemia in adults.一项关于成人血清25-羟维生素D水平与高脂血症风险的队列研究。
Front Nutr. 2025 Jan 24;11:1492621. doi: 10.3389/fnut.2024.1492621. eCollection 2024.
7
Bridging the Gap: Supplements Strategies from Experimental Research to Clinical Applications in Sarcopenic Obesity.弥合差距:从肌肉减少性肥胖的实验研究到临床应用的补充策略
Curr Issues Mol Biol. 2024 Nov 24;46(12):13418-13430. doi: 10.3390/cimb46120800.
8
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.双重负担:探索慢性肾脏病中的心血管并发症。
Biomolecules. 2024 Oct 31;14(11):1393. doi: 10.3390/biom14111393.
9
Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach.维生素D与髋部保护器在肌少性骨质疏松症中的应用:一种联合预防髋部骨折的方法
Rev Endocr Metab Disord. 2025 Feb;26(1):1-18. doi: 10.1007/s11154-024-09907-8. Epub 2024 Oct 1.
10
Obesity and lipid metabolism in the development of osteoporosis (Review).肥胖与脂代谢在骨质疏松症发病中的作用(综述)。
Int J Mol Med. 2024 Jul;54(1). doi: 10.3892/ijmm.2024.5385. Epub 2024 May 31.
定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Clin Nutr. 2022 Apr;41(4):990-1000. doi: 10.1016/j.clnu.2021.11.014. Epub 2022 Feb 22.
4
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review.肌肉减少症的发病机制与脂肪量的关系:描述性综述。
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):781-794. doi: 10.1002/jcsm.12901. Epub 2022 Feb 2.
5
Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial.大剂量维生素 D 补充对 DXA 评估的老年人肌少症和肥胖相关指标的影响:一项随机对照试验。
Endocrine. 2022 Apr;76(1):162-171. doi: 10.1007/s12020-021-02951-3. Epub 2022 Jan 14.
6
Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines.肌少症和肌少症性肥胖的多因素机制。身体活动、微生物组和肌因子的作用。
Cells. 2022 Jan 4;11(1):160. doi: 10.3390/cells11010160.
7
Effect of Vitamin D Supplementation on Glycemic Control in Prediabetes: A Meta-Analysis.维生素D补充剂对糖尿病前期血糖控制的影响:一项荟萃分析。
Nutrients. 2021 Dec 14;13(12):4464. doi: 10.3390/nu13124464.
8
Vitamin D Deficiency Is Inversely Associated with Homeostatic Model Assessment of Insulin Resistance.维生素 D 缺乏与稳态模型评估的胰岛素抵抗呈负相关。
Nutrients. 2021 Dec 3;13(12):4358. doi: 10.3390/nu13124358.
9
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?维生素 D:剂量、水平、形式和给药途径:一种方法适合所有人吗?
Rev Endocr Metab Disord. 2021 Dec;22(4):1201-1218. doi: 10.1007/s11154-021-09693-7. Epub 2021 Dec 23.
10
A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity.代谢综合征因素与肌骨减少性肥胖的相关性研究。
BMC Endocr Disord. 2021 Oct 29;21(1):216. doi: 10.1186/s12902-021-00880-w.